Estimated reading time: about 20 minutesFor my son's middle school entrance exams, I have always believed that sleep was the ...

The Department of Nursing in the Faculty of Nursing at Kyushu International University will open in April 2027. The ...

Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...

Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

Inflammaging is a state of persistent, low-grade inflammation associated with aging, influenced by immune dysfunction, ...

The therapeutic options for patients with inflammatory bowel disease (IBD) have recently expanded substantially. Tofacitinib, ...

Biological sciences encompasses all the divisions of natural sciences examining various aspects of vital processes. The concept includes anatomy, physiology, cell biology, biochemistry and biophysics, ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more. The ...

In college, your to-do list can go from zero to overwhelming in about five minutes. One second you’re grabbing coffee, the next you’ve got a paper due, a shift at work, and a group project to plan.

GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as the first and only immunotherapy for adults with stage II and III ...

A near-infrared fluorescent choline kinase α inhibitor, JAS239, was used to identify tumors in canine patients.